Почетна › Рак (све врсте) › Тенеси › Nashville
Kliničke studije za Рак (све врсте) u gradu Nashville, TN
65 studija za Рак (све врсте) traži učesnike na lokacijama u gradu Nashville i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Тражи се учесникФаза 3
- Sarah Cannon Research Institute, Nashville
Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes
Тражи се учесникФаза 2
- Vanderbilt University Medical Center, Nashville
A Study of YL242 in Subjects With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- US-205, Nashville
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Тражи се учесникФаза 1
- Vanderbilt Ingram Cancer Center /ID# 252470, Nashville
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Тражи се учесникФаза 3
- Vanderbilt Breast Center at One Hundred Oaks, Nashville
- Vanderbilt University/Ingram Cancer Center, Nashville
- Vanderbilt-Ingram Cancer Center at Franklin, Franklin · 17 ми удаљено
- и још 1
Pan Tumor Rollover Study
Тражи се учесникФаза 2
- Tennesse Oncology, Nashville
- Local Institution - 0066, Nashville
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- SCRI Oncology Partners - PPDS, Nashville
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Тражи се учесникФаза 3
- Vanderbilt University Medical Center, Nashville
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Тражи се учесникФаза 1
- Sarah Cannon Cancer Institute, Nashville
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Тражи се учесникФаза 3
- Tennessee Oncology, Nashville
- USO - US Oncology Research Network, Nashville
A Study of JNJ-87890387 for Advanced Solid Tumors
Тражи се учесникФаза 1
- Sarah Cannon Research Institute, Nashville
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Тражи се учесникФаза 2/3
- Sarah Cannon Research Inst, Nashville
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Тражи се учесникФаза 3
- Sarah Cannon Research Institute at TriStar Centennial Medical Center, Nashville
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Тражи се учесникФаза 3
- SCRI Oncology Partners, Nashville
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Тражи се учесникФаза 1
- Research Site, Nashville
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Тражи се учесникОпсервациона студија
- Vanderbilt University Medical Center, Nashville
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
Тражи се учесникФаза 3
- SCRI Oncology Partners ( Site 7000), Nashville
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Тражи се учесникФаза 3
- Research Site, Nashville
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Тражи се учесникФаза 1/2
- Tennessee Oncology, Nashville
Galleri® in the Medicare Population.
Тражи се учесникЗдраве особе су добродошле
- HCA Healthcare Centennial, Nashville
- HCA Healthcare Nashville, Nashville
- HCA Healthcare Brentwood, Brentwood · 9 ми удаљено
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
Тражи се учесникРана фаза 1
- Vanderbilt University Medical Center, Nashville
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Тражи се учесникФаза 2/3
- Henry-Joyce Cancer Clinic, Nashville
A Study of ASP3082 in Adults With Advanced Solid Tumors
Тражи се учесникФаза 1
- Vanderbilt University Medical Center, Nashville
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Тражи се учесникФаза 2
- SCRI Oncology Partners /ID# 274522, Nashville
Suprachoroidal Administration in Subjects With Metastases to the Choroid
Тражи се учесникФаза 2
- Tennessee Retina, PC, Nashville
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Sarah Cannon Research Institute, Nashville
- Vanderbilt Ingram Cancer Center, Nashville
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Тражи се учесникФаза 2/3
- SCRI Oncology Partners /ID# 276959, Nashville
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Тражи се учесникФаза 2
- SCRI Oncology Partners /ID# 279733, Nashville
A Study of PHN-012 in Patients With Advanced Solid Tumors
Тражи се учесникФаза 1
- PHN-012-001 Site, Nashville
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Тражи се учесникОпсервациона студија
- Vanderbilt University Medical Center, Nashville
Registry Study for Radiation Therapy Outcomes
Тражи се учесникОпсервациона студија
- Tennessee Oncology Proton Center, Franklin · 17 ми удаљено
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
Тражи се учесникФаза 1
- SCRI Oncology Partners, Nashville
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- GSK Investigational Site, Nashville
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Тражи се учесникФаза 3
- SCRI Oncology Partners /ID# 279779, Nashville
- Vanderbilt University Medical Center /ID# 280169, Nashville
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Тражи се учесникФаза 2
- Tennessee Oncology - Nashville / Sarah Cannon Research Institute, Nashville
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Тражи се учесникФаза 1/2
- Sarah Cannon Research Institue, Nashville
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
Тражи се учесникФаза 1/2
- GSK Investigational Site, Nashville
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- Sarah Cannon Research Center, Nashville
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Тражи се учесникФаза 1
- SCRI Oncology Partners, Nashville
- Vanderbilt Ingram Cancer Center, Nashville
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Тражи се учесникОпсервациона студија
- Vanderbilt University, Nashville
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Тражи се учесникФаза 3
- Tennessee Oncology PLLC - Chattanooga, Nashville
- Tennessee Oncology, PLLC, Nashville
- Vanderbilt University Medical Center, Nashville
Project: Every Child for Younger Patients With Cancer
Тражи се учесникОпсервациона студија
- The Children's Hospital at TriStar Centennial, Nashville
- Vanderbilt University/Ingram Cancer Center, Nashville
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Sarah Cannon Research Institute Oncology Partners (SCRI-Nashville), Nashville
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- SCRI Oncology Partners, Nashville
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Sara Cannon Research Institute Tennessee, Nashville
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Тражи се учесникФаза 2
- Vanderbilt University, Ingram Cancer Center, Nashville
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Sarah Cannon Research Institute, Nashville
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
Тражи се учесникФаза 1
- GSK Investigational Site, Nashville
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
Тражи се учесникФаза 1
- Sarah Cannon, SCRI Oncology Partners, Nashville
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Тражи се учесникФаза 1/2
- Vanderbilt University Medical Center, Nashville
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
Тражи се учесникФаза 1
- GSK Investigational Site, Nashville
Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma
Тражи се учесникФаза 1
- Vanderbilt University Medical Center, Nashville
High-Resolution PET-CT Imaging for Surgical Margin Visualization
Тражи се учесник
- Vanderbilt University Medical Center, Nashville
Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy
Тражи се учесникРана фаза 1
- Vanderbilt University Medical Center, Nashville
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- Sarah Cannon Research Institute, Nashville
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Тражи се учесникФаза 1
- SCRI Oncology Partners, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- SCRI Oncology Partners, Nashville
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Тражи се учесникФаза 1
- Vanderbilt-Ingram Cancer Center, Nashville
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
Тражи се учесникФаза 1
- Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Тражи се учесникОпсервациона студија
- Massive Bio SYNERGY-AI site, Nashville
Inherited CAncer REgistry
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Vanderbilt-Ingram Cancer Center, Nashville
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Sarah Cannon Research Institute, Nashville
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Тражи се учесникФаза 1/2
- SCRI Oncology Partners, Nashville
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Тражи се учесникФаза 1/2
- Verdi Oncology Tennessee, Scri Oncology Partners, Nashville
Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up
Тражи се учесникОпсервациона студија
- Provision CARES Proton Therapy Nashville, Franklin · 17 ми удаљено
Studije za Рак (све врсте) u drugim gradovima
- Houston, TX124 студија
- New York City, NY105 студија
- Boston, MA90 студија
- Los Angeles, CA73 студија
- Durham, NC61 студија
- Washington, DC60 студија
- Philadelphia, PA57 студија
- Arlington, VA52 студија
- Chicago, IL51 студија
- St. Louis, MO51 студија
- Atlanta, GA49 студија
- Seattle, WA48 студија
Ostale studije u gradu Nashville
- Немалоклетни карцином плућа97 студија
- Рак дојке78 студија
- Метастатски карцином69 студија
- Колоректални карцином67 студија
- Рак јајника50 студија
- Плоскоклеточни карцином главе и врата43 студија
- Рак простате40 студија
- Рак панкреаса39 студија
- Рак плућа39 студија
- Карцином ендометријума38 студија
- Меланом34 студија
- Рак бешике31 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.